{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T14:11:50Z","timestamp":1795011110595,"version":"4.9.1"},"reference-count":213,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008594","name":"European Hematology Association","doi-asserted-by":"publisher","award":["RG-70"],"award-info":[{"award-number":["RG-70"]}],"id":[{"id":"10.13039\/100008594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013136","name":"Office of Sex Offender Sentencing, Monitoring, Apprehending, Registering, and Tracking","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013136","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB1036"],"award-info":[{"award-number":["SFB1036"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FerrOs - FOR5146"],"award-info":[{"award-number":["FerrOs - FOR5146"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1053\/j.seminhematol.2021.05.001","type":"journal-article","created":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T19:30:34Z","timestamp":1623526234000},"page":"132-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["20 years of Hepcidin: How far we have come"],"prefix":"10.1053","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0816-9009","authenticated-orcid":false,"given":"Silvia","family":"Colucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriana","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6781-1073","authenticated-orcid":false,"given":"Sandro","family":"Altamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1053\/j.seminhematol.2021.05.001_bib0001","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1574-6968.1983.tb00504.x","article-title":"Lactobacillus plantarum, an organism not requiring iron","volume":"19","author":"Archibald","year":"1983","journal-title":"FEMS Microbiol Lett"},{"issue":"9","key":"10.1053\/j.seminhematol.2021.05.001_bib0002","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1039\/c8mt00146d","article-title":"The human iron-proteome","volume":"10","author":"Andreini","year":"2018","journal-title":"Metallomics"},{"issue":"5","key":"10.1053\/j.seminhematol.2021.05.001_bib0003","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"19","key":"10.1053\/j.seminhematol.2021.05.001_bib0004","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1182\/blood-2018-04-842997","article-title":"Ferroportin deficiency in erythroid cells causes serum iron deficiency and promotes hemolysis due to oxidative stress","volume":"132","author":"Zhang","year":"2018","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.seminhematol.2021.05.001_bib0005","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2141.1987.tb01291.x","article-title":"Non-transferrin plasma iron","volume":"66","author":"Hershko","year":"1987","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1053\/j.seminhematol.2021.05.001_bib0006","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1017\/S1368980008002401","article-title":"Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005","volume":"12","author":"McLean","year":"2009","journal-title":"Public Health Nutr"},{"issue":"11","key":"10.1053\/j.seminhematol.2021.05.001_bib0007","doi-asserted-by":"crossref","first-page":"7806","DOI":"10.1074\/jbc.M008922200","article-title":"Hepcidin, a urinary antimicrobial peptide synthesized in the liver","volume":"276","author":"Park","year":"2001","journal-title":"J Biol Chem"},{"issue":"2\u20133","key":"10.1053\/j.seminhematol.2021.05.001_bib0008","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0014-5793(00)01920-7","article-title":"LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity","volume":"480","author":"Krause","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1053\/j.seminhematol.2021.05.001_bib0009","doi-asserted-by":"crossref","unstructured":"Valore E V, Ganz T. Posttranslational processing of hepcidin in human hepatocytes is mediated by the prohormone convertase furin. Blood Cells Mol Dis. 40(1):132\u20138.","DOI":"10.1016\/j.bcmd.2007.07.009"},{"issue":"40","key":"10.1053\/j.seminhematol.2021.05.001_bib0010","doi-asserted-by":"crossref","first-page":"37597","DOI":"10.1074\/jbc.M205305200","article-title":"The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis","volume":"277","author":"Hunter","year":"2002","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1053\/j.seminhematol.2021.05.001_bib0011","doi-asserted-by":"crossref","first-page":"7811","DOI":"10.1074\/jbc.M008923200","article-title":"A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload","volume":"276","author":"Pigeon","year":"2001","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1053\/j.seminhematol.2021.05.001_bib0012","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng1053","article-title":"Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis","volume":"33","author":"Roetto","year":"2003","journal-title":"Nat Genet"},{"issue":"4","key":"10.1053\/j.seminhematol.2021.05.001_bib0013","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1182\/blood-2006-02-003376","article-title":"Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis","volume":"108","author":"Lesbordes-Brion","year":"2006","journal-title":"Blood"},{"issue":"15","key":"10.1053\/j.seminhematol.2021.05.001_bib0014","doi-asserted-by":"crossref","first-page":"8780","DOI":"10.1073\/pnas.151179498","article-title":"Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice","volume":"98","author":"Nicolas","year":"2001","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"23","key":"10.1053\/j.seminhematol.2021.05.001_bib0015","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1182\/blood-2014-01-550467","article-title":"Targeted disruption of hepcidin in the liver recapitulates the hemochromatotic phenotype","volume":"123","author":"Zumerle","year":"2014","journal-title":"Blood"},{"issue":"7","key":"10.1053\/j.seminhematol.2021.05.001_bib0016","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.1073\/pnas.072632499","article-title":"Severe iron deficiency anemia in transgenic mice expressing liver hepcidin","volume":"99","author":"Nicolas","year":"2002","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"4","key":"10.1053\/j.seminhematol.2021.05.001_bib0017","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s11248-015-9879-3","article-title":"Inductively coupled mass spectrometry analysis of biometals in conditional Hamp1 and Hamp1 and Hamp2 transgenic mouse models","volume":"24","author":"Lu","year":"2015","journal-title":"Transgenic Res"},{"issue":"10","key":"10.1053\/j.seminhematol.2021.05.001_bib0018","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1182\/blood-2002-04-1260","article-title":"Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease","volume":"100","author":"Weinstein","year":"2002","journal-title":"Blood"},{"issue":"7","key":"10.1053\/j.seminhematol.2021.05.001_bib0019","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1182\/blood-2002-10-3235","article-title":"Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein","volume":"101","author":"Nemeth","year":"2003","journal-title":"Blood"},{"issue":"5704","key":"10.1053\/j.seminhematol.2021.05.001_bib0020","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science"},{"issue":"2","key":"10.1053\/j.seminhematol.2021.05.001_bib0021","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1097-2765(00)80425-6","article-title":"A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation","volume":"5","author":"McKie","year":"2000","journal-title":"Mol Cell"},{"issue":"6771","key":"10.1053\/j.seminhematol.2021.05.001_bib0022","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/35001596","article-title":"Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter","volume":"403","author":"Donovan","year":"2000","journal-title":"Nature"},{"issue":"26","key":"10.1053\/j.seminhematol.2021.05.001_bib0023","doi-asserted-by":"crossref","first-page":"19906","DOI":"10.1074\/jbc.M000713200","article-title":"A novel mammalian iron-regulated protein involved in intracellular iron metabolism","volume":"275","author":"Abboud","year":"2000","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1053\/j.seminhematol.2021.05.001_bib0024","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cmet.2005.01.003","article-title":"The iron exporter ferroportin\/Slc40a1 is essential for iron homeostasis","volume":"1","author":"Donovan","year":"2005","journal-title":"Cell Metab"},{"key":"10.1053\/j.seminhematol.2021.05.001_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2020.100872","article-title":"Regulation of iron homeostasis: lessons from mouse models","volume":"75","author":"Altamura","year":"2020","journal-title":"Mol Aspects Med"},{"issue":"1","key":"10.1053\/j.seminhematol.2021.05.001_bib0026","doi-asserted-by":"crossref","first-page":"C75","DOI":"10.1152\/ajpcell.00621.2008","article-title":"Functional analysis and theoretical modeling of ferroportin reveals clustering of mutations according to phenotype","volume":"298","author":"Wallace","year":"2010","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1053\/j.seminhematol.2021.05.001_bib0027","doi-asserted-by":"crossref","first-page":"8545","DOI":"10.1038\/ncomms9545","article-title":"Outward- and inward-facing structures of a putative bacterial transition-metal transporter with homology to ferroportin","volume":"6","author":"Taniguchi","year":"2015","journal-title":"Nat Commun"},{"issue":"1","key":"10.1053\/j.seminhematol.2021.05.001_bib0028","doi-asserted-by":"crossref","first-page":"5686","DOI":"10.1038\/s41467-020-19458-6","article-title":"Structural basis of ion transport and inhibition in ferroportin","volume":"11","author":"Pan","year":"2020","journal-title":"Nat Commun"},{"issue":"7831","key":"10.1053\/j.seminhematol.2021.05.001_bib0029","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41586-020-2668-z","article-title":"Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms","volume":"586","author":"Billesb\u00f8lle","year":"2020","journal-title":"Nature"},{"key":"10.1053\/j.seminhematol.2021.05.001_bib0030","doi-asserted-by":"crossref","unstructured":"Pignatti E, Mascheroni L, Sabelli M, Barelli S, Biffo S, Pietrangelo A. Ferroportin is a monomer in vivo in mice. Blood Cells Mol Dis. 36(1):26\u201332.","DOI":"10.1016\/j.bcmd.2005.11.001"},{"key":"10.1053\/j.seminhematol.2021.05.001_bib0031","doi-asserted-by":"crossref","unstructured":"Schimanski LM, Drakesmith H, Talbott C, et al. Ferroportin: lack of evidence for multimers. Blood Cells Mol Dis. 40(3):360\u20139.","DOI":"10.1016\/j.bcmd.2007.09.007"},{"issue":"5","key":"10.1053\/j.seminhematol.2021.05.001_bib0032","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1002\/hep.29007","article-title":"Human macrophage ferroportin biology and the basis for the ferroportin disease","volume":"65","author":"Sabelli","year":"2017","journal-title":"Hepatology"},{"issue":"5","key":"10.1053\/j.seminhematol.2021.05.001_bib0033","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1182\/blood-2006-06-032516","article-title":"Evidence for the multimeric structure of ferroportin","volume":"109","author":"De Domenico","year":"2007","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.seminhematol.2021.05.001_bib0034","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20191499","article-title":"Evidence for dimerization of ferroportin in a human hepatic cell line using proximity ligation assays","volume":"40","author":"Rishi","year":"2020","journal-title":"Biosci Rep"},{"issue":"1","key":"10.1053\/j.seminhematol.2021.05.001_bib0035","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1038\/s41467-018-05446-4","article-title":"Calcium is an essential cofactor for metal efflux by the ferroportin transporter family","volume":"9","author":"Deshpande","year":"2018","journal-title":"Nat Commun"},{"issue":"1","key":"10.1053\/j.seminhematol.2021.05.001_bib0036","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1182\/blood-2005-05-2049","article-title":"The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study","volume":"107","author":"Nemeth","year":"2006","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2021.05.001_bib0037","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cmet.2012.03.018","article-title":"Hepcidin-induced endocytosis of ferroportin is dependent on ferroportin ubiquitination","volume":"15","author":"Qiao","year":"2012","journal-title":"Cell Metab"},{"key":"10.1053\/j.seminhematol.2021.05.001_bib0038","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2020008986","article-title":"RNF217 regulates iron homeostasis through its E3 ubiquitin ligase activity by modulating ferroportin degradation","author":"Jiang","year":"2021","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.seminhematol.2021.05.001_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2020.129829","article-title":"The role of cellular iron deficiency in controlling iron export","volume":"1865","author":"Link","year":"2021","journal-title":"Biochim Biophys acta Gen Subj"},{"issue":"8","key":"10.1053\/j.seminhematol.2021.05.001_bib0040","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1182\/blood-2017-05-786590","article-title":"Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin","volume":"131","author":"Aschemeyer","year":"2018","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2021.05.001_bib0041","first-page":"71","volume":"110","author":"Silvestri","year":"2019"},{"issue":"3","key":"10.1053\/j.seminhematol.2021.05.001_bib0042","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/MOH.0000000000000236","article-title":"Hepcidin regulation in the anemia of inflammation","volume":"23","author":"Wang","year":"2016","journal-title":"Curr Opin Hematol"},{"issue":"5","key":"10.1053\/j.seminhematol.2021.05.001_bib0043","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00109-008-0313-7","article-title":"A bone morphogenetic protein (BMP)-responsive element in the hepcidin promoter controls HFE2-mediated hepatic hepcidin expression and its response to IL-6 in cultured cells","volume":"86","author":"Verga Falzacappa","year":"2008","journal-title":"J Mol Med (Berl)"},{"issue":"10","key":"10.1053\/j.seminhematol.2021.05.001_bib0044","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1182\/blood-2010-08-303859","article-title":"Blunted hepcidin response to inflammation in the absence of Hfe and transferrin receptor 2","volume":"117","author":"Wallace","year":"2011","journal-title":"Blood"},{"issue":"17","key":"10.1053\/j.seminhematol.2021.05.001_bib0045","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1182\/blood-2018-03-841197","article-title":"Hepcidin-mediated hypoferremic response to acute inflammation requires a threshold of Bmp6\/Hjv\/Smad signaling","volume":"132","author":"Fillebeen","year":"2018","journal-title":"Blood"},{"issue":"14","key":"10.1053\/j.seminhematol.2021.05.001_bib0046","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1182\/blood-2013-02-480095","article-title":"The type I BMP receptor Alk3 is required for the induction of hepatic hepcidin gene expression by interleukin-6","volume":"123","author":"Mayeur","year":"2014","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2021.05.001_bib0047","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cmet.2005.10.010","article-title":"A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression","volume":"2","author":"Wang","year":"2005","journal-title":"Cell Metab"},{"issue":"5942","key":"10.1053\/j.seminhematol.2021.05.001_bib0048","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1126\/science.1176639","article-title":"ER stress controls iron metabolism through induction of hepcidin","volume":"325","author":"Vecchi","year":"2009","journal-title":"Science"},{"issue":"4","key":"10.1053\/j.seminhematol.2021.05.001_bib0049","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.3324\/haematol.2019.237321","article-title":"Endoplasmic reticulum stress controls iron metabolism through TMPRSS6 repression and hepcidin mRNA stabilization by RNA-binding protein HuR","volume":"106","author":"Belot","year":"2021","journal-title":"Haematologica"},{"issue":"6","key":"10.1053\/j.seminhematol.2021.05.001_bib0050","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1002\/hep.30780","article-title":"Ablation of hepatocyte Smad1, Smad5, and Smad8 causes severe tissue iron loading and liver fibrosis in mice","volume":"70","author":"Wang","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"10.1053\/j.seminhematol.2021.05.001_bib0051","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1182\/blood-2016-12-759423","article-title":"Smad1\/5 is required for erythropoietin-mediated suppression of hepcidin in mice","volume":"130","author":"Wang","year":"2017","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminhematol.2021.05.001_bib0052","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cellsig.2010.10.003","article-title":"Bone morphogenetic proteins: a critical review","volume":"23","author":"Bragdon","year":"2011","journal-title":"Cell Signal"},{"issue":"13","key":"10.1053\/j.seminhematol.2021.05.001_bib0053","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1182\/blood-2014-04-572644","article-title":"BMP type II receptors have redundant roles in the regulation of hepatic hepcidin gene expression and iron metabolism","volume":"124","author":"Mayeur","year":"2014","journal-title":"Blood"},{"issue":"15","key":"10.1053\/j.seminhematol.2021.05.001_bib0054","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1182\/blood-2011-03-339952","article-title":"Perturbation of hepcidin expression by BMP type I receptor deletion induces iron overload in mice","volume":"118","author":"Steinbicker","year":"2011","journal-title":"Blood"},{"issue":"6958","key":"10.1053\/j.seminhematol.2021.05.001_bib0055","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature02006","article-title":"Smad-dependent and Smad-independent pathways in TGF-beta family signalling","volume":"425","author":"Derynck","year":"2003","journal-title":"Nature"},{"issue":"37","key":"10.1053\/j.seminhematol.2021.05.001_bib0056","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.1038\/sj.onc.1208928","article-title":"Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis","volume":"24","author":"Javelaud","year":"2005","journal-title":"Oncogene"},{"issue":"Pt 21","key":"10.1053\/j.seminhematol.2021.05.001_bib0057","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1242\/jcs.03228","article-title":"TfR2 localizes in lipid raft domains and is released in exosomes to activate signal transduction along the MAPK pathway","volume":"119","author":"Calzolari","year":"2006","journal-title":"J Cell Sci"},{"issue":"6","key":"10.1053\/j.seminhematol.2021.05.001_bib0058","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3324\/haematol.2008.003541","article-title":"Cross-talk between the mitogen activated protein kinase and bone morphogenetic protein\/hemojuvelin pathways is required for the induction of hepcidin by holotransferrin in primary mouse hepatocytes","volume":"94","author":"Ramey","year":"2009","journal-title":"Haematologica"},{"issue":"11","key":"10.1053\/j.seminhematol.2021.05.001_bib0059","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.3324\/haematol.2010.027003","article-title":"Transferrin receptor 2 and HFE regulate furin expression via mitogen-activated protein kinase\/extracellular signal-regulated kinase (MAPK\/Erk) signaling. Implications for transferrin-dependent hepcidin regulation","volume":"95","author":"Poli","year":"2010","journal-title":"Haematologica"},{"issue":"3","key":"10.1053\/j.seminhematol.2021.05.001_bib0060","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3324\/haematol.2015.127902","article-title":"Increased hepcidin in transferrin-treated thalassemic mice correlates with increased liver BMP2 expression and decreased hepatocyte ERK activation","volume":"101","author":"Chen","year":"2016","journal-title":"Haematologica"},{"issue":"10","key":"10.1053\/j.seminhematol.2021.05.001_bib0061","first-page":"e493-e493","article-title":"Hemochromatosis proteins are dispensable for the acute hepcidin response to BMP2","volume":"105","author":"Pagani","year":"2020","journal-title":"Haematologica"},{"issue":"5","key":"10.1053\/j.seminhematol.2021.05.001_bib0062","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ng1777","article-title":"Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression","volume":"38","author":"Babitt","year":"2006","journal-title":"Nat Genet"},{"issue":"9","key":"10.1053\/j.seminhematol.2021.05.001_bib0063","doi-asserted-by":"crossref","first-page":"e46307","DOI":"10.1371\/journal.pone.0046307","article-title":"Repulsive guidance molecule (RGM) family proteins exhibit differential binding kinetics for bone morphogenetic proteins (BMPs)","volume":"7","author":"Wu","year":"2012","journal-title":"PLoS One"},{"key":"10.1053\/j.seminhematol.2021.05.001_bib0064","doi-asserted-by":"crossref","unstructured":"Lin L, Nemeth E, Goodnough JB, Thapa DR, Gabayan V, Ganz T. Soluble hemojuvelin is released by proprotein convertase-mediated cleavage at a conserved polybasic RNRR site. Blood Cells Mol Dis. 40(1):122\u201331.","DOI":"10.1016\/j.bcmd.2007.06.023"},{"issue":"2","key":"10.1053\/j.seminhematol.2021.05.001_bib0065","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1182\/blood-2007-07-100677","article-title":"Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis","volume":"111","author":"Silvestri","year":"2008","journal-title":"Blood"},{"issue":"8","key":"10.1053\/j.seminhematol.2021.05.001_bib0066","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1182\/blood-2005-05-1845","article-title":"Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin","volume":"106","author":"Lin","year":"2005","journal-title":"Blood"},{"issue":"7","key":"10.1053\/j.seminhematol.2021.05.001_bib0067","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1172\/JCI31342","article-title":"Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance","volume":"117","author":"Babitt","year":"2007","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1053\/j.seminhematol.2021.05.001_bib0068","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nsmb.3016","article-title":"Repulsive guidance molecule is a structural bridge between neogenin and bone morphogenetic protein","volume":"22","author":"Healey","year":"2015","journal-title":"Nat Struct Mol Biol"},{"issue":"40","key":"10.1053\/j.seminhematol.2021.05.001_bib0069","doi-asserted-by":"crossref","first-page":"33885","DOI":"10.1074\/jbc.M506207200","article-title":"Interaction of hemojuvelin with neogenin results in iron accumulation in human embryonic kidney 293 cells","volume":"280","author":"Zhang","year":"2005","journal-title":"J Biol Chem"},{"issue":"15","key":"10.1053\/j.seminhematol.2021.05.001_bib0070","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1182\/blood-2009-11-251199","article-title":"Neogenin inhibits HJV secretion and regulates BMP-induced hepcidin expression and iron homeostasis","volume":"115","author":"Lee","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2021.05.001_bib0071","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2020009485","article-title":"Hepatocyte neogenin is required for hemojuvelin-mediated hepcidin expression and iron homeostasis in mice","author":"Enns","year":"2021","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2021.05.001_bib0072","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.cmet.2008.09.012","article-title":"The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin","volume":"8","author":"Silvestri","year":"2008","journal-title":"Cell Metab"},{"issue":"3","key":"10.1053\/j.seminhematol.2021.05.001_bib0073","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1182\/blood-2011-04-348698","article-title":"Regulation of TMPRSS6 by BMP6 and iron in human cells and mice","volume":"118","author":"Meynard","year":"2011","journal-title":"Blood"},{"issue":"50","key":"10.1053\/j.seminhematol.2021.05.001_bib0074","doi-asserted-by":"crossref","first-page":"39021","DOI":"10.1074\/jbc.M110.183160","article-title":"Matriptase-2- and proprotein convertase-cleaved forms of hemojuvelin have different roles in the down-regulation of hepcidin expression","volume":"285","author":"Maxson","year":"2010","journal-title":"J Biol Chem"},{"issue":"5879","key":"10.1053\/j.seminhematol.2021.05.001_bib0075","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1126\/science.1157121","article-title":"The serine protease TMPRSS6 is required to sense iron deficiency","volume":"320","author":"Du","year":"2008","journal-title":"Science"},{"issue":"6","key":"10.1053\/j.seminhematol.2021.05.001_bib0076","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1182\/blood-2008-04-149773","article-title":"Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis","volume":"112","author":"Folgueras","year":"2008","journal-title":"Blood"},{"issue":"44","key":"10.1053\/j.seminhematol.2021.05.001_bib0077","doi-asserted-by":"crossref","first-page":"18354","DOI":"10.1074\/jbc.M117.801795","article-title":"Matriptase-2 suppresses hepcidin expression by cleaving multiple components of the hepcidin induction pathway","volume":"292","author":"Wahedi","year":"2017","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1053\/j.seminhematol.2021.05.001_bib0078","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3324\/haematol.2013.103143","article-title":"The erythroid function of transferrin receptor 2 revealed by Tmprss6 inactivation in different models of transferrin receptor 2 knockout mice","volume":"99","author":"Nai","year":"2014","journal-title":"Haematologica"},{"issue":"17","key":"10.1053\/j.seminhematol.2021.05.001_bib0079","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1182\/blood-2010-10-315507","article-title":"Tmprss6 is a genetic modifier of the Hfe-hemochromatosis phenotype in mice","volume":"117","author":"Finberg","year":"2011","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminhematol.2021.05.001_bib0080","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ng0896-399","article-title":"A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis","volume":"13","author":"Feder","year":"1996","journal-title":"Nat Genet"},{"issue":"1","key":"10.1053\/j.seminhematol.2021.05.001_bib0081","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00109-003-0508-x","article-title":"Iron overload in adult Hfe-deficient mice independent of changes in the steady-state expression of the duodenal iron transporters DMT1 and Ireg1\/ferroportin","volume":"82","author":"Herrmann","year":"2004","journal-title":"J Mol Med"},{"issue":"2","key":"10.1053\/j.seminhematol.2021.05.001_bib0082","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cmet.2007.11.014","article-title":"Hfe acts in hepatocytes to prevent hemochromatosis","volume":"7","author":"Vuji\u0107 Spasi\u0107","year":"2008","journal-title":"Cell Metab"},{"issue":"8","key":"10.1053\/j.seminhematol.2021.05.001_bib0083","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1182\/blood-2014-01-552281","article-title":"HFE interacts with the BMP type I receptor ALK3 to regulate hepcidin expression","volume":"124","author":"Wu","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminhematol.2021.05.001_bib0084","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1053\/j.gastro.2009.06.057","article-title":"Bone morphogenetic protein signaling is impaired in an HFE knockout mouse model of hemochromatosis","volume":"137","author":"Corradini","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1053\/j.seminhematol.2021.05.001_bib0085","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.freeradbiomed.2020.08.023","article-title":"HFE and ALK3 act in the same signaling pathway","volume":"160","author":"Traeger","year":"2020","journal-title":"Free Radic Biol Med"},{"issue":"30","key":"10.1053\/j.seminhematol.2021.05.001_bib0086","doi-asserted-by":"crossref","first-page":"20826","DOI":"10.1074\/jbc.274.30.20826","article-title":"Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family","volume":"274","author":"Kawabata","year":"1999","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1053\/j.seminhematol.2021.05.001_bib0087","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1182\/blood.V98.6.1949","article-title":"Regulation of expression of murine transferrin receptor 2","volume":"98","author":"Kawabata","year":"2001","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.seminhematol.2021.05.001_bib0088","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1091\/mbc.e06-09-0798","article-title":"Transferrin receptor 2: evidence for ligand-induced stabilization and redirection to a recycling pathway","volume":"18","author":"Johnson","year":"2007","journal-title":"Mol Biol Cell"},{"issue":"4","key":"10.1053\/j.seminhematol.2021.05.001_bib0089","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3324\/haematol.2014.118521","article-title":"Regulation of cell surface transferrin receptor-2 by iron-dependent cleavage and release of a soluble form","volume":"100","author":"Pagani","year":"2015","journal-title":"Haematologica"},{"issue":"1","key":"10.1053\/j.seminhematol.2021.05.001_bib0090","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/75534","article-title":"The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22","volume":"25","author":"Camaschella","year":"2000","journal-title":"Nat Genet"},{"issue":"7","key":"10.1053\/j.seminhematol.2021.05.001_bib0091","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1136\/gut.2004.062018","article-title":"First phenotypic description of transferrin receptor 2 knockout mouse, and the role of hepcidin","volume":"54","author":"Wallace","year":"2005","journal-title":"Gut"},{"issue":"1","key":"10.1053\/j.seminhematol.2021.05.001_bib0092","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1053\/j.gastro.2006.11.028","article-title":"Targeted disruption of the hepatic transferrin receptor 2 gene in mice leads to iron overload","volume":"132","author":"Wallace","year":"2007","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1053\/j.seminhematol.2021.05.001_bib0093","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1053\/j.gastro.2011.06.077","article-title":"Iron regulation of hepcidin despite attenuated Smad1,5,8 signaling in mice without transferrin receptor 2 or Hfe","volume":"141","author":"Corradini","year":"2011","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1053\/j.seminhematol.2021.05.001_bib0094","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cmet.2009.01.010","article-title":"Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression","volume":"9","author":"Gao","year":"2009","journal-title":"Cell Metab"},{"issue":"5","key":"10.1053\/j.seminhematol.2021.05.001_bib0095","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.jhep.2012.06.015","article-title":"The hemochromatosis proteins HFE, TfR2, and HJV form a membrane-associated protein complex for hepcidin regulation","volume":"57","author":"D'Alessio","year":"2012","journal-title":"J Hepatol"},{"issue":"6","key":"10.1053\/j.seminhematol.2021.05.001_bib0096","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1002\/hep.23198","article-title":"Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload","volume":"50","author":"Wallace","year":"2009","journal-title":"Hepatology"},{"issue":"10","key":"10.1053\/j.seminhematol.2021.05.001_bib0097","doi-asserted-by":"crossref","first-page":"e77267","DOI":"10.1371\/journal.pone.0077267","article-title":"In situ proximity ligation assays indicate that hemochromatosis proteins Hfe and transferrin receptor 2 (Tfr2) do not interact","volume":"8","author":"Rishi","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1053\/j.seminhematol.2021.05.001_bib0098","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s42255-018-0005-8","article-title":"Transferrin receptor 2 controls bone mass and pathological bone formation via BMP and Wnt signalling","volume":"1","author":"Rauner","year":"2019","journal-title":"Nat Metab"},{"issue":"10","key":"10.1053\/j.seminhematol.2021.05.001_bib0099","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.3324\/haematol.2019.241984","article-title":"Hemochromatosis proteins are dispensable for the acute hepcidin response to BMP2","volume":"105","author":"Pagani","year":"2020","journal-title":"Haematologica"},{"issue":"19","key":"10.1053\/j.seminhematol.2021.05.001_bib0100","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1182\/blood-2017-04-780692","article-title":"The immunophilin FKBP12 inhibits hepcidin expression by binding the BMP type I receptor ALK2 in hepatocytes","volume":"130","author":"Colucci","year":"2017","journal-title":"Blood"},{"issue":"25","key":"10.1053\/j.seminhematol.2021.05.001_bib0101","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1182\/blood-2017-03-773481","article-title":"A new form of due to combined heterozygous mutations of TMPRSS6 and ACVR1A encoding the BMP receptor ALK2","volume":"129","author":"Pagani","year":"2017","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.seminhematol.2021.05.001_bib0102","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2016.12.034","article-title":"A Red carpet for iron metabolism","volume":"168","author":"Muckenthaler","year":"2017","journal-title":"Cell"},{"issue":"4","key":"10.1053\/j.seminhematol.2021.05.001_bib0103","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3324\/haematol.2010.033449","article-title":"A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis","volume":"96","author":"Girelli","year":"2011","journal-title":"Haematologica"},{"issue":"4","key":"10.1053\/j.seminhematol.2021.05.001_bib0104","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ng.335","article-title":"BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism","volume":"41","author":"Andriopoulos","year":"2009","journal-title":"Nat Genet"},{"issue":"10","key":"10.1053\/j.seminhematol.2021.05.001_bib0105","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1182\/blood-2007-09-111567","article-title":"Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin","volume":"111","author":"Xia","year":"2008","journal-title":"Blood"},{"issue":"11","key":"10.1053\/j.seminhematol.2021.05.001_bib0106","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/ajh.24888","article-title":"Bone morphogenetic protein 2 controls iron homeostasis in mice independent of Bmp6","volume":"92","author":"Canali","year":"2017","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1053\/j.seminhematol.2021.05.001_bib0107","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1182\/blood-2016-07-729822","article-title":"Angiocrine Bmp2 signaling in murine liver controls normal iron homeostasis","volume":"129","author":"Koch","year":"2017","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminhematol.2021.05.001_bib0108","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1182\/blood-2016-06-721571","article-title":"Endothelial cells produce bone morphogenetic protein 6 required for iron homeostasis in mice","volume":"129","author":"Canali","year":"2017","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminhematol.2021.05.001_bib0109","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/ng.320","article-title":"Lack of the bone morphogenetic protein BMP6 induces massive iron overload","volume":"41","author":"Meynard","year":"2009","journal-title":"Nat Genet"},{"issue":"4","key":"10.1053\/j.seminhematol.2021.05.001_bib0110","doi-asserted-by":"crossref","first-page":"e60534","DOI":"10.1371\/journal.pone.0060534","article-title":"Increased iron loading induces Bmp6 expression in the non-parenchymal cells of the liver independent of the BMP-signaling pathway","volume":"8","author":"a","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1053\/j.seminhematol.2021.05.001_bib0111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0122696","article-title":"Bmp6 expression in murine liver non parenchymal cells: a mechanism to control their high iron exporter activity and protect hepatocytes from iron overload?","volume":"10","author":"Rausa","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1053\/j.seminhematol.2021.05.001_bib0112","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/hep.31048","article-title":"Endothelial Bone Morphogenetic Protein 2 (Bmp2) Knockout Exacerbates Hemochromatosis in Homeostatic Iron Regulator (Hfe) Knockout Mice but not Bmp6 Knockout Mice","volume":"72","author":"Xiao","year":"2020","journal-title":"Hepatology"},{"issue":"1","key":"10.1053\/j.seminhematol.2021.05.001_bib0113","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/hep.24359","article-title":"Serum and liver iron differently regulate the bone morphogenetic protein 6 (BMP6)-SMAD signaling pathway in mice","volume":"54","author":"Corradini","year":"2011","journal-title":"Hepatology"},{"issue":"4","key":"10.1053\/j.seminhematol.2021.05.001_bib0114","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1182\/blood-2008-03-143354","article-title":"Iron regulates phosphorylation of Smad1\/5\/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver","volume":"112","author":"Kautz","year":"2008","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.seminhematol.2021.05.001_bib0115","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s42255-019-0063-6","article-title":"Nrf2 controls iron homeostasis in haemochromatosis and thalassaemia via Bmp6 and hepcidin","volume":"1","author":"Lim","year":"2019","journal-title":"Nat Metab"},{"issue":"1","key":"10.1053\/j.seminhematol.2021.05.001_bib0116","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00264-014-2550-4","article-title":"Exogenous BMP7 corrects plasma iron overload and bone loss in Bmp6-\/- mice","volume":"39","author":"Pauk","year":"2015","journal-title":"Int Orthop"},{"key":"10.1053\/j.seminhematol.2021.05.001_bib0117","doi-asserted-by":"crossref","unstructured":"Nicolas G, Viatte L, Bennoun M, Beaumont C, Kahn A, Vaulont S. Hepcidin, a new iron regulatory peptide. Blood Cells Mol Dis. 29(3):327\u201335.","DOI":"10.1006\/bcmd.2002.0573"},{"issue":"12","key":"10.1053\/j.seminhematol.2021.05.001_bib0118","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1182\/blood-2006-06-028787","article-title":"Suppression of hepcidin during anemia requires erythropoietic activity","volume":"108","author":"Pak","year":"2006","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2021.05.001_bib0119","doi-asserted-by":"crossref","first-page":"667","DOI":"10.33549\/physiolres.930841","article-title":"Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis","volume":"55","author":"Vokurka","year":"2006","journal-title":"Physiol Res"},{"issue":"6","key":"10.1053\/j.seminhematol.2021.05.001_bib0120","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s12185-012-1217-4","article-title":"Erythropoietin stimulation decreases hepcidin expression through hematopoietic activity on bone marrow cells in mice","volume":"96","author":"Sasaki","year":"2012","journal-title":"Int J Hematol"},{"issue":"9","key":"10.1053\/j.seminhematol.2021.05.001_bib0121","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nm1629","article-title":"High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin","volume":"13","author":"Tanno","year":"2007","journal-title":"Nat Med"},{"issue":"12","key":"10.1053\/j.seminhematol.2021.05.001_bib0122","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1136\/gutjnl-2013-305317","article-title":"Hypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor BB","volume":"63","author":"Sonnweber","year":"2014","journal-title":"Gut"},{"issue":"7","key":"10.1053\/j.seminhematol.2021.05.001_bib0123","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/ng.2996","article-title":"Identification of erythroferrone as an erythroid regulator of iron metabolism","volume":"46","author":"Kautz","year":"2014","journal-title":"Nat Genet"},{"issue":"14","key":"10.1053\/j.seminhematol.2021.05.001_bib0124","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2018-06-857995","article-title":"Erythroferrone inhibits the induction of hepcidin by BMP6","volume":"132","author":"Arezes","year":"2018","journal-title":"Blood"},{"issue":"8","key":"10.1053\/j.seminhematol.2021.05.001_bib0125","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1182\/blood.2019003140","article-title":"Antibodies against the erythroferrone N-terminal domain prevent hepcidin suppression and ameliorate murine thalassemia","volume":"135","author":"Arezes","year":"2020","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2021.05.001_bib0126","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood.2019002620","article-title":"Erythroferrone lowers hepcidin by sequestering BMP2\/6 heterodimer from binding to the BMP type I receptor ALK3","volume":"135","author":"Wang","year":"2020","journal-title":"Blood"},{"issue":"19","key":"10.1053\/j.seminhematol.2021.05.001_bib0127","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1182\/blood-2015-11-681494","article-title":"Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice","volume":"127","author":"Nai","year":"2016","journal-title":"Blood"},{"issue":"22","key":"10.1053\/j.seminhematol.2021.05.001_bib0128","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1091\/mbc.e10-04-0348","article-title":"Heparan sulfate acts as a bone morphogenetic protein coreceptor by facilitating ligand-induced receptor hetero-oligomerization","volume":"21","author":"Kuo","year":"2010","journal-title":"Mol Biol Cell"},{"issue":"36","key":"10.1053\/j.seminhematol.2021.05.001_bib0129","doi-asserted-by":"crossref","first-page":"13292","DOI":"10.1074\/jbc.RA118.007213","article-title":"Hepatic heparan sulfate is a master regulator of hepcidin expression and iron homeostasis in human hepatocytes and mice","volume":"294","author":"Poli","year":"2019","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1053\/j.seminhematol.2021.05.001_bib0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2020.129799","article-title":"BMP6 binding to heparin and heparan sulfate is mediated by N-terminal and C-terminal clustered basic residues","volume":"1865","author":"Denardo","year":"2021","journal-title":"Biochim Biophys acta Gen Subj"},{"issue":"3","key":"10.1053\/j.seminhematol.2021.05.001_bib0131","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1182\/blood-2010-06-289082","article-title":"Heparin: a potent inhibitor of hepcidin expression in vitro and in vivo","volume":"117","author":"Poli","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.seminhematol.2021.05.001_bib0132","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bcp.2014.09.007","article-title":"Oversulfated heparins with low anticoagulant activity are strong and fast inhibitors of hepcidin expression in vitro and in vivo","volume":"92","author":"Poli","year":"2014","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"10.1053\/j.seminhematol.2021.05.001_bib0133","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22040598","article-title":"Non-anticoagulant heparins are hepcidin antagonists for the treatment of anemia","volume":"22","author":"Poli","year":"2017","journal-title":"Molecules"},{"issue":"2","key":"10.1053\/j.seminhematol.2021.05.001_bib0134","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/ndt\/gfr288","article-title":"Testosterone deficiency is a cause of anaemia and reduced responsiveness to erythropoiesis-stimulating agents in men with chronic kidney disease","volume":"27","author":"Carrero","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1053\/j.seminhematol.2021.05.001_bib0135","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s10653-015-9758-0","article-title":"Analysis of the relationship between the blood concentration of several metals, macro- and micronutrients and endocrine disorders associated with male aging","volume":"38","author":"Rotter","year":"2016","journal-title":"Environ Geochem Health"},{"issue":"4","key":"10.1053\/j.seminhematol.2021.05.001_bib0136","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/13685538.2016.1229764","article-title":"The relationship between serum total testosterone and free testosterone levels with serum hemoglobin and hematocrit levels: a study in 1221 men","volume":"19","author":"Shin","year":"2016","journal-title":"Aging Male"},{"issue":"6","key":"10.1053\/j.seminhematol.2021.05.001_bib0137","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1210\/jc.2009-2575","article-title":"Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis","volume":"95","author":"Fern\u00e1ndez-Balsells","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1053\/j.seminhematol.2021.05.001_bib0138","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1210\/jc.2010-0864","article-title":"Testosterone suppresses hepcidin in men: a potential mechanism for testosterone-induced erythrocytosis","volume":"95","author":"Bachman","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1053\/j.seminhematol.2021.05.001_bib0139","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/acel.12052","article-title":"Testosterone administration inhibits hepcidin transcription and is associated with increased iron incorporation into red blood cells","volume":"12","author":"Guo","year":"2013","journal-title":"Aging Cell"},{"issue":"5","key":"10.1053\/j.seminhematol.2021.05.001_bib0140","first-page":"1","article-title":"Testosterone perturbs systemic iron balance through activation of EGFR signaling in the liver and repression of hepcidin","author":"Latour","year":"2013","journal-title":"Hepatology"},{"issue":"1","key":"10.1053\/j.seminhematol.2021.05.001_bib0141","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.25615","article-title":"Inhibition of hepcidin transcription by growth factors","volume":"56","author":"Goodnough","year":"2012","journal-title":"Hepatology"},{"issue":"14","key":"10.1053\/j.seminhematol.2021.05.001_bib0142","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/j.febslet.2012.02.035","article-title":"Spatial regulation of BMP activity","volume":"586","author":"Ramel","year":"2012","journal-title":"FEBS Lett"},{"issue":"2","key":"10.1053\/j.seminhematol.2021.05.001_bib0143","first-page":"189","volume":"100","author":"Wrana","year":"2000","journal-title":"Regulation of Smad Activity. Cell."},{"issue":"3","key":"10.1053\/j.seminhematol.2021.05.001_bib0144","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022095","article-title":"Regulation of TGF-\u03b2 family signaling by inhibitory smads","volume":"9","author":"Miyazawa","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"13","key":"10.1053\/j.seminhematol.2021.05.001_bib0145","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1182\/blood-2009-09-238105","article-title":"SMAD7 controls iron metabolism as a potent inhibitor of hepcidin expression","volume":"115","author":"Mleczko-Sanecka","year":"2010","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.seminhematol.2021.05.001_bib0146","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1182\/blood-2017-07-796797","article-title":"Hepatic Smad7 overexpression causes severe iron overload in mice","volume":"131","author":"Lai","year":"2018","journal-title":"Blood"},{"issue":"6752","key":"10.1053\/j.seminhematol.2021.05.001_bib0147","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/46794","article-title":"Silencing of TGF-beta signalling by the pseudoreceptor BAMBI","volume":"401","author":"Onichtchouk","year":"1999","journal-title":"Nature"},{"issue":"5","key":"10.1053\/j.seminhematol.2021.05.001_bib0148","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1042\/BST20160111","article-title":"Modulation of BMP signalling by integrins","volume":"44","author":"Ashe","year":"2016","journal-title":"Biochem Soc Trans"},{"issue":"6","key":"10.1053\/j.seminhematol.2021.05.001_bib0149","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1074\/jbc.M111.310789","article-title":"BMPER protein is a negative regulator of hepcidin and is up-regulated in hypotransferrinemic mice*","volume":"287","author":"Patel","year":"2012","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1053\/j.seminhematol.2021.05.001_bib0150","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00535-016-1237-6","article-title":"Bone morphogenetic protein-binding endothelial regulator of liver sinusoidal endothelial cells induces iron overload in a fatty liver mouse model","volume":"52","author":"Hasebe","year":"2017","journal-title":"J Gastroenterol"},{"issue":"3","key":"10.1053\/j.seminhematol.2021.05.001_bib0151","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF02981951","article-title":"Role of jak kinases and STATs in cytokine signal transduction","volume":"73","author":"Leonard","year":"2001","journal-title":"Int J Hematol"},{"issue":"9","key":"10.1053\/j.seminhematol.2021.05.001_bib0152","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI200420945","article-title":"IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin","volume":"113","author":"Nemeth","year":"2004","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1053\/j.seminhematol.2021.05.001_bib0153","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1182\/blood-2012-02-411470","article-title":"Induction of activin B by inflammatory stimuli up-regulates expression of the iron-regulatory peptide hepcidin through Smad1\/5\/8 signaling","volume":"120","author":"Besson-Fournier","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.seminhematol.2021.05.001_bib0154","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1210\/en.2015-1747","article-title":"Activin B Induces Noncanonical SMAD1\/5\/8 Signaling via BMP Type I Receptors in Hepatocytes: Evidence for a Role in Hepcidin Induction by Inflammation in Male Mice","volume":"157","author":"Canali","year":"2016","journal-title":"Endocrinology"},{"issue":"4","key":"10.1053\/j.seminhematol.2021.05.001_bib0155","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1182\/blood-2016-10-748541","article-title":"Hepcidin upregulation by inflammation is independent of Smad1\/5\/8 signaling by activin B","volume":"129","author":"Besson-Fournier","year":"2017","journal-title":"Blood"},{"issue":"22","key":"10.1053\/j.seminhematol.2021.05.001_bib0156","doi-asserted-by":"crossref","first-page":"13316","DOI":"10.1021\/acs.jmedchem.0c00884","article-title":"Myeloid Differentiation Primary Response Protein 88 (MyD88): the central hub of TLR\/IL-1R signaling","volume":"63","author":"Chen","year":"2020","journal-title":"J Med Chem"},{"key":"10.1053\/j.seminhematol.2021.05.001_bib0157","first-page":"9","article-title":"MyD88 adaptor protein is required for appropriate hepcidin induction in response to dietary iron overload in mice","author":"Layoun","year":"2018","journal-title":"Front Physiol"},{"issue":"9","key":"10.1053\/j.seminhematol.2021.05.001_bib0158","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1182\/blood-2005-06-2259","article-title":"TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens","volume":"107","author":"Peyssonnaux","year":"2006","journal-title":"Blood"},{"issue":"12","key":"10.1053\/j.seminhematol.2021.05.001_bib0159","doi-asserted-by":"crossref","first-page":"e408","DOI":"10.1038\/emm.2017.207","article-title":"Hepatocyte toll-like receptor 4 mediates lipopolysaccharide-induced hepcidin expression","volume":"49","author":"Lee","year":"2017","journal-title":"Exp Mol Med"},{"issue":"5","key":"10.1053\/j.seminhematol.2021.05.001_bib0160","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3324\/haematol.2016.160432","article-title":"Pathophysiological consequences and benefits of HFE mutations: 20 years of research","volume":"102","author":"Hollerer","year":"2017","journal-title":"Haematologica"},{"issue":"1","key":"10.1053\/j.seminhematol.2021.05.001_bib0161","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jhep.2010.03.001","article-title":"European association for the study of the liver. EASL clinical practice guidelines for HFE hemochromatosis","volume":"53","year":"2010","journal-title":"J Hepatol"},{"issue":"1","key":"10.1053\/j.seminhematol.2021.05.001_bib0162","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/ng1274","article-title":"Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis","volume":"36","author":"Papanikolaou","year":"2004","journal-title":"Nat Genet"},{"issue":"4","key":"10.1053\/j.seminhematol.2021.05.001_bib0163","first-page":"526","article-title":"The effect of repeated phlebotomies in hemochromatosis; report of three cases","volume":"39","author":"WD","year":"1952","journal-title":"J Lab Clin Med"},{"key":"10.1053\/j.seminhematol.2021.05.001_bib0164","doi-asserted-by":"crossref","unstructured":"Sham RL, Phatak PD, West C, Lee P, Andrews C, Beutler E. Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features. Blood Cells Mol Dis. 34(2):157\u201361.","DOI":"10.1016\/j.bcmd.2004.12.002"},{"issue":"6","key":"10.1053\/j.seminhematol.2021.05.001_bib0165","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/imj.12764","article-title":"Novel gain of function mutation in the SLC40A1 gene associated with hereditary haemochromatosis type 4","volume":"45","author":"Chen","year":"2015","journal-title":"Intern Med J"},{"issue":"3","key":"10.1053\/j.seminhematol.2021.05.001_bib0166","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood-2005-02-0561","article-title":"Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin","volume":"106","author":"Drakesmith","year":"2005","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminhematol.2021.05.001_bib0167","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jhep.2003.12.008","article-title":"Autosomal dominant iron overload due to a novel mutation of ferroportin1 associated with parenchymal iron loading and cirrhosis","volume":"40","author":"Wallace","year":"2004","journal-title":"J Hepatol"},{"issue":"8","key":"10.1053\/j.seminhematol.2021.05.001_bib0168","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1136\/gut.52.8.1215","article-title":"A novel mutation in ferroportin1 is associated with haemochromatosis in a Solomon Islands patient","volume":"52","author":"Arden","year":"2003","journal-title":"Gut"},{"issue":"3","key":"10.1053\/j.seminhematol.2021.05.001_bib0169","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/90038","article-title":"A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis","volume":"28","author":"Njajou","year":"2001","journal-title":"Nat Genet"},{"issue":"3","key":"10.1053\/j.seminhematol.2021.05.001_bib0170","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2141.2009.07834.x","article-title":"A novel missense mutation in SLC40A1 results in resistance to hepcidin and confirms the existence of two ferroportin-associated iron overload diseases","volume":"147","author":"L\u00e9tocart","year":"2009","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1053\/j.seminhematol.2021.05.001_bib0171","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1053\/j.gastro.2011.02.064","article-title":"Identification of mutations in SLC40A1 that affect ferroportin function and phenotype of human ferroportin iron overload","volume":"140","author":"Mayr","year":"2011","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1053\/j.seminhematol.2021.05.001_bib0172","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.cmet.2014.07.007","article-title":"Resistance of ferroportin to hepcidin binding causes exocrine pancreatic failure and fatal iron overload","volume":"20","author":"Altamura","year":"2014","journal-title":"Cell Metab"},{"issue":"10270","key":"10.1053\/j.seminhematol.2021.05.001_bib0173","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(20)32594-0","article-title":"Iron deficiency","volume":"397","author":"Pasricha","year":"2021","journal-title":"Lancet"},{"issue":"6","key":"10.1053\/j.seminhematol.2021.05.001_bib0174","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3324\/haematol.2012.075515","article-title":"Iron refractory iron deficiency anemia","volume":"98","author":"De Falco","year":"2013","journal-title":"Haematologica"},{"issue":"12","key":"10.1053\/j.seminhematol.2021.05.001_bib0175","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJMra1804281","article-title":"Anemia of inflammation","volume":"381","author":"Ganz","year":"2019","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1053\/j.seminhematol.2021.05.001_bib0176","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.3324\/haematol.2015.140772","article-title":"Anti-hemojuvelin antibody corrects anemia caused by inappropriately high hepcidin levels","volume":"101","author":"Kovac","year":"2016","journal-title":"Haematologica"},{"issue":"8","key":"10.1053\/j.seminhematol.2021.05.001_bib0177","doi-asserted-by":"crossref","first-page":"e385","DOI":"10.3324\/haematol.2019.236133","article-title":"LJ000328, a novel ALK2\/3 kinase inhibitor, represses hepcidin and significantly improves the phenotype of IRIDA","volume":"105","author":"Belot","year":"2020","journal-title":"Haematologica"},{"issue":"19","key":"10.1053\/j.seminhematol.2021.05.001_bib0178","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1182\/blood-2015-11-681494","article-title":"Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice","volume":"127","author":"Nai","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2021.05.001_bib0179","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12931-020-01546-2","article-title":"Persisting alterations of iron homeostasis in COVID-19 are associated with non-resolving lung pathologies and poor patients\u2019 performance: a prospective observational cohort study","volume":"21","author":"Sonnweber","year":"2020","journal-title":"Respir Res"},{"issue":"6","key":"10.1053\/j.seminhematol.2021.05.001_bib0180","doi-asserted-by":"crossref","first-page":"e492","DOI":"10.1097\/HS9.0000000000000492","article-title":"Hypoferremia is associated with increased hospitalization and oxygen demand in COVID-19 patients","volume":"4","author":"Hippchen","year":"2020","journal-title":"HemaSphere"},{"issue":"1","key":"10.1053\/j.seminhematol.2021.05.001_bib0181","doi-asserted-by":"crossref","first-page":"E32","DOI":"10.1002\/ajh.26027","article-title":"Hepcidin levels predict Covid-19 severity and mortality in a cohort of hospitalized Italian patients","volume":"96","author":"Nai","year":"2021","journal-title":"Am J Hematol"},{"issue":"10","key":"10.1053\/j.seminhematol.2021.05.001_bib0182","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.3899\/jrheum.110339","article-title":"Serum hepcidin: a direct link between anemia of inflammation and coronary artery atherosclerosis in patients with rheumatoid arthritis","volume":"38","author":"Abdel-Khalek","year":"2011","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1053\/j.seminhematol.2021.05.001_bib0183","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3324\/haematol.2014.112813","article-title":"The role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational study","volume":"100","author":"Macci\u00f2","year":"2015","journal-title":"Haematologica"},{"issue":"6","key":"10.1053\/j.seminhematol.2021.05.001_bib0184","doi-asserted-by":"crossref","first-page":"F1369","DOI":"10.1152\/ajprenal.00281.2016","article-title":"Effects of dietary iron intake and chronic kidney disease on fibroblast growth factor 23 metabolism in wild-type and hepcidin knockout mice","volume":"311","author":"Hanudel","year":"2016","journal-title":"Am J Physiol Physiol"},{"issue":"3","key":"10.1053\/j.seminhematol.2021.05.001_bib0185","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1182\/blood-2017-03-772715","article-title":"Endogenous hepcidin and its agonist mediate resistance to selected infections by clearing non\u2013transferrin-bound iron","volume":"130","author":"Stefanova","year":"2017","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2021.05.001_bib0186","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/ajh.20644","article-title":"Use of breath carbon monoxide measurements to assess erythrocyte survival in subjects with chronic diseases","volume":"81","author":"Mitlyng","year":"2006","journal-title":"Am J Hematol"},{"issue":"10116","key":"10.1053\/j.seminhematol.2021.05.001_bib0187","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(17)31822-6","article-title":"Thalassaemia","volume":"391","author":"Taher","year":"2018","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2021.05.001_bib0188","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/S0268-960X(12)70006-1","article-title":"Iron overload in non-transfusion-dependent thalassemia: a clinical perspective","volume":"26","author":"Musallam","year":"2012","journal-title":"Blood Rev"},{"issue":"17","key":"10.1053\/j.seminhematol.2021.05.001_bib0189","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1182\/blood-2015-07-658419","article-title":"Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of \u03b2-thalassemia","volume":"126","author":"Kautz","year":"2015","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.seminhematol.2021.05.001_bib0190","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2015-10-676742","article-title":"Minihepcidin peptides as disease modifiers in mice affected by \u03b2-thalassemia and polycythemia vera","volume":"128","author":"Casu","year":"2016","journal-title":"Blood"},{"issue":"7","key":"10.1053\/j.seminhematol.2021.05.001_bib0191","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3324\/haematol.2018.212589","article-title":"Minihepcidins improve ineffective erythropoiesis and splenomegaly in a new mouse model of adult \u03b2-thalassemia major","volume":"105","author":"Casu","year":"2020","journal-title":"Haematologica"},{"issue":"Supplement_1","key":"10.1053\/j.seminhematol.2021.05.001_bib0192","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2019-129309","article-title":"Regulation of iron homeostasis By PTG-300 improves disease parameters in mouse models for beta-thalassemia and hereditary hemochromatosis","volume":"134","author":"Taranath","year":"2019","journal-title":"Blood"},{"issue":"21","key":"10.1053\/j.seminhematol.2021.05.001_bib0193","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1182\/blood-2012-01-401885","article-title":"Deletion of TMPRSS6 attenuates the phenotype in a mouse model of \u03b2-thalassemia","volume":"119","author":"Nai","year":"2012","journal-title":"Blood"},{"issue":"7","key":"10.1053\/j.seminhematol.2021.05.001_bib0194","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood-2012-09-453977","article-title":"An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-\/-) mice and ameliorates anemia and iron overload in murine \u03b2-thalassemia intermedia","volume":"121","author":"Schmidt","year":"2013","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminhematol.2021.05.001_bib0195","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1172\/JCI66969","article-title":"Reducing TMPRSS6 ameliorates hemochromatosis and \u03b2-thalassemia in mice","volume":"123","author":"Guo","year":"2013","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1053\/j.seminhematol.2021.05.001_bib0196","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.3324\/haematol.2015.133348","article-title":"Combination of Tmprss6- ASO and the iron chelator deferiprone improves erythropoiesis and reduces iron overload in a mouse model of beta-thalassemia intermedia","volume":"101","author":"Casu","year":"2016","journal-title":"Haematologica"},{"issue":"Supplement 1","key":"10.1053\/j.seminhematol.2021.05.001_bib0197","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2018-99-115339","article-title":"Transmembrane Protease, Serine 6 (TMPRSS6) Antisense Oligonucleotide (IONIS-TMPRSS6-LRX) Reduces Plasma Iron Levels of Healthy Volunteers in a Phase 1 Clinical Study","volume":"132","author":"McCaleb","year":"2018","journal-title":"Blood."},{"issue":"Supplement 1","key":"10.1053\/j.seminhematol.2021.05.001_bib0198","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2018-99-110163","article-title":"SLN124, a Galnac-siRNA Conjugate Targeting TMPRSS6, for the treatment of iron overload and ineffective erythropoiesis such as in beta-thalassemia","volume":"132","author":"Altamura","year":"2018","journal-title":"Blood."},{"issue":"1","key":"10.1053\/j.seminhematol.2021.05.001_bib0199","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1182\/blood-2018-07-815928","article-title":"Iron metabolism under conditions of ineffective erythropoiesis in \u03b2-thalassemia","volume":"133","author":"Rivella","year":"2019","journal-title":"Blood"},{"issue":"18","key":"10.1053\/j.seminhematol.2021.05.001_bib0200","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1182\/blood-2011-03-345066","article-title":"Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats","volume":"118","author":"Theurl","year":"2011","journal-title":"Blood"},{"issue":"Supplement 1","key":"10.1053\/j.seminhematol.2021.05.001_bib0201","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2020-140323","article-title":"Administration of KER-047, a Novel ALK2 inhibitor, elicited robust and sustained increases in serum iron in healthy participants","volume":"136","author":"Ordonez","year":"2020","journal-title":"Blood"},{"issue":"23","key":"10.1053\/j.seminhematol.2021.05.001_bib0202","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V126.23.273.273","article-title":"ALK2 Inhibition Via TP-0184 abrogates inflammation-induced hepcidin expression and is a potential therapeutic for anemia of chronic disease","volume":"126","author":"Peterson","year":"2015","journal-title":"Blood"},{"issue":"22","key":"10.1053\/j.seminhematol.2021.05.001_bib0203","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V128.22.263.263","article-title":"The ALK-2 Inhibitor, TP-0184, demonstrates high distribution to the liver contributing to significant preclinical efficacy in mouse models of anemia of chronic disease","volume":"128","author":"Peterson","year":"2016","journal-title":"Blood"},{"issue":"13","key":"10.1053\/j.seminhematol.2021.05.001_bib0204","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1182\/blood-2016-09-740092","article-title":"Momelotinib inhibits ACVR1\/ALK2, decreases hepcidin production, and ameliorates anemia of chronic disease in rodents","volume":"129","author":"Asshoff","year":"2017","journal-title":"Blood"},{"issue":"34","key":"10.1053\/j.seminhematol.2021.05.001_bib0205","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1200\/JCO.2017.73.4418","article-title":"SIMPLIFY-1: a Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor-Na\u00efve patients with myelofibrosis","volume":"35","author":"Mesa","year":"2017","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1053\/j.seminhematol.2021.05.001_bib0206","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212023","article-title":"First-in-human Phase I studies of PRS-080#22, a hepcidin antagonist, in healthy volunteers and patients with chronic kidney disease undergoing hemodialysis","volume":"14","author":"Renders","year":"2019","journal-title":"PLoS One"},{"key":"10.1053\/j.seminhematol.2021.05.001_bib0207","series-title":"Clinical Research (Excluding Clinical Trials).","article-title":"The anti-hepcidin Spiegelmer\u00ae Lexaptepid Pegol (NOX-H94) as treatment of anemia of chronic disease in patients with multiple myeloma, low grade lymphoma, and CLL: A phase II pilot study","author":"Georgiev","year":"2014"},{"issue":"17","key":"10.1053\/j.seminhematol.2021.05.001_bib0208","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1182\/blood-2009-09-245977","article-title":"Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia","volume":"115","author":"Sasu","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2021.05.001_bib0209","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13045-017-0427-x","article-title":"A first-in-human phase 1 study of a hepcidin monoclonal antibody, LY2787106, in cancer-associated anemia","volume":"10","author":"Vadhan-Raj","year":"2017","journal-title":"J Hematol Oncol"},{"issue":"5","key":"10.1053\/j.seminhematol.2021.05.001_bib0210","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/bcp.13877","article-title":"Targeting the hepcidin-ferroportin pathway in anaemia of chronic kidney disease","volume":"85","author":"Sheetz","year":"2019","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"10.1053\/j.seminhematol.2021.05.001_bib0211","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3390\/ijms22020873","article-title":"The Oral Ferroportin Inhibitor VIT-2763 improves erythropoiesis without interfering with iron chelation therapy in a mouse model of \u03b2-Thalassemia","volume":"22","author":"Nyffenegger","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1053\/j.seminhematol.2021.05.001_bib0212","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1172\/JCI129382","article-title":"Oral ferroportin inhibitor ameliorates ineffective erythropoiesis in a model of \u03b2-thalassemia","volume":"130","author":"Manolova","year":"2019","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1053\/j.seminhematol.2021.05.001_bib0213","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1097\/HS9.0000000000000301","article-title":"SLN124, a GalNAc-siRNA conjugate targeting TMPRSS6, efficiently prevents iron overload in hereditary haemochromatosis Type 1","volume":"3","author":"Altamura","year":"2019","journal-title":"HemaSphere"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196321000305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196321000305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:55:32Z","timestamp":1778622932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196321000305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":213,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0037196321000305"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2021.05.001","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"20 years of Hepcidin: How far we have come","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2021.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}